NCT03123614View on ClinicalTrials.gov

Loteprednol vs. Prednisolone and Fluorometholone

PHASE4CompletedINTERVENTIONAL
Enrollment

131

Participants

Timeline

Start Date

September 19, 2014

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Intraocular PressureCorneal Opacity
Interventions
DRUG

Loteprednol Etabonate 0.5% Oph Gel

DRUG

Prednisolone Acetate 1% Oph Susp

Trial Locations (1)

84107

Moran Eye Center - Midvalley Location, Murray

All Listed Sponsors
lead

University of Utah

OTHER

NCT03123614 - Loteprednol vs. Prednisolone and Fluorometholone | Biotech Hunter | Biotech Hunter